S K Malin1, J P Kirwan. 1. Department of Pathobiology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195, USA.
Abstract
AIM: Lifestyle modification, consisting of exercise and weight loss, delays the progression from prediabetes to type 2 diabetes (T2D). However, no study has determined the efficacy of exercise training on glucose metabolism in the different prediabetes subtypes. METHODS: Seventy-six older (65.1 ± 0.6 years) obese adults with impaired fasting glucose (IFG; n = 12), impaired glucose tolerance (IGT; n = 9) and combined glucose intolerance (IFG + IGT = CGI; n = 22) were compared with normal glucose tolerant (NGT; n = 15) and T2D (n = 18) groups after 12 weeks of exercise training (60 min/day for 5 days/week at ~85% HR(max)). An oral glucose tolerance test was used to assess glucose levels. Insulin sensitivity (IS; euglycaemic hyperinsulinaemic clamp at 40 mU/m(2)/min), β-cell function (glucose-stimulated insulin secretion corrected for IS), body composition (hydrostatic weighing/computed tomography scan) and cardiovascular fitness (treadmill VO(2) max) were also assessed. RESULTS: Exercise training reduced weight and increased cardiovascular fitness (p < 0.05). Exercise training lowered fasting glucose levels in IFG, CGI and T2D (p < 0.05) and 2-h glucose levels in IGT, CGI and T2D (p < 0.05). However, 2-h glucose levels were not normalized in adults with CGI compared with IGT (p < 0.05). β-Cell function improved similarly across groups (p < 0.05). Although not statistically significant, IS increased approximately 40% in IFG and IGT, but only 17% in CGI. CONCLUSION: The magnitude of improvement in glucose metabolism after 12 weeks of exercise training is not uniform across the prediabetes subtypes. Given the high risk of progressing to T2D, adults with CGI may require more aggressive therapies to prevent diabetes.
AIM: Lifestyle modification, consisting of exercise and weight loss, delays the progression from prediabetes to type 2 diabetes (T2D). However, no study has determined the efficacy of exercise training on glucose metabolism in the different prediabetes subtypes. METHODS: Seventy-six older (65.1 ± 0.6 years) obese adults with impaired fasting glucose (IFG; n = 12), impaired glucose tolerance (IGT; n = 9) and combined glucose intolerance (IFG + IGT = CGI; n = 22) were compared with normal glucose tolerant (NGT; n = 15) and T2D (n = 18) groups after 12 weeks of exercise training (60 min/day for 5 days/week at ~85% HR(max)). An oral glucose tolerance test was used to assess glucose levels. Insulin sensitivity (IS; euglycaemic hyperinsulinaemic clamp at 40 mU/m(2)/min), β-cell function (glucose-stimulated insulin secretion corrected for IS), body composition (hydrostatic weighing/computed tomography scan) and cardiovascular fitness (treadmill VO(2) max) were also assessed. RESULTS: Exercise training reduced weight and increased cardiovascular fitness (p < 0.05). Exercise training lowered fasting glucose levels in IFG, CGI and T2D (p < 0.05) and 2-h glucose levels in IGT, CGI and T2D (p < 0.05). However, 2-h glucose levels were not normalized in adults with CGI compared with IGT (p < 0.05). β-Cell function improved similarly across groups (p < 0.05). Although not statistically significant, IS increased approximately 40% in IFG and IGT, but only 17% in CGI. CONCLUSION: The magnitude of improvement in glucose metabolism after 12 weeks of exercise training is not uniform across the prediabetes subtypes. Given the high risk of progressing to T2D, adults with CGI may require more aggressive therapies to prevent diabetes.
Authors: Valerie B O'Leary; Christine M Marchetti; Raj K Krishnan; Bradley P Stetzer; Frank Gonzalez; John P Kirwan Journal: J Appl Physiol (1985) Date: 2005-12-22
Authors: Muhammad A Abdul-Ghani; Christopher P Jenkinson; Dawn K Richardson; Devjit Tripathy; Ralph A DeFronzo Journal: Diabetes Date: 2006-05 Impact factor: 9.461
Authors: X R Pan; G W Li; Y H Hu; J X Wang; W Y Yang; Z X An; Z X Hu; J Lin; J Z Xiao; H B Cao; P A Liu; X G Jiang; Y Y Jiang; J P Wang; H Zheng; H Zhang; P H Bennett; B V Howard Journal: Diabetes Care Date: 1997-04 Impact factor: 19.112
Authors: Flemming Dela; Michael E von Linstow; Kári Joensen Mikines; Henrik Galbo Journal: Am J Physiol Endocrinol Metab Date: 2004-07-13 Impact factor: 4.310
Authors: V A Hughes; M A Fiatarone; R A Fielding; B B Kahn; C M Ferrara; P Shepherd; E C Fisher; R R Wolfe; D Elahi; W J Evans Journal: Am J Physiol Date: 1993-06
Authors: Joyce S Ramos; Lance C Dalleck; Fabio Borrani; Alistair R Mallard; Bronwyn Clark; Shelley E Keating; Robert G Fassett; Jeff S Coombes Journal: Diabetologia Date: 2016-08-01 Impact factor: 10.122
Authors: Fabiana S Evangelista; Cynthia R Muller; Jose T Stefano; Mariana M Torres; Bruna R Muntanelli; Daniel Simon; Mario R Alvares-da-Silva; Isabel V Pereira; Bruno Cogliati; Flair J Carrilho; Claudia P Oliveira Journal: Int J Clin Exp Med Date: 2015-07-15
Authors: Monica C Serra; Jacob B Blumenthal; Odessa R Addison; Ann J Miller; Andrew P Goldberg; Alice S Ryan Journal: Ann Nutr Metab Date: 2017-06-09 Impact factor: 3.374
Authors: Steven K Malin; Kristi R Hinnerichs; Brandon G Echtenkamp; Tammy K Evetovich; Barbara J Engebretsen Journal: Eur J Appl Physiol Date: 2013-09-27 Impact factor: 3.078
Authors: Steven K Malin; Thomas P J Solomon; Alecia Blaszczak; Stephen Finnegan; Julianne Filion; John P Kirwan Journal: Am J Physiol Endocrinol Metab Date: 2013-09-17 Impact factor: 4.310
Authors: Thomas P J Solomon; Steven K Malin; Kristian Karstoft; Sangeeta R Kashyap; Jacob M Haus; John P Kirwan Journal: J Clin Endocrinol Metab Date: 2013-08-21 Impact factor: 5.958
Authors: Thomas P J Solomon; Steven K Malin; Kristian Karstoft; Jacob M Haus; John P Kirwan Journal: JAMA Intern Med Date: 2013-10-28 Impact factor: 21.873